[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@TheCapitalJunky](/creator/twitter/TheCapitalJunky) "Chevron Tesla and Oracle Lead Wave of Companies Leaving California by 2025 Over High Costs and Regulations"  [@TheCapitalJunky](/creator/x/TheCapitalJunky) on [X](/post/tweet/1949897675454705878) 2025-07-28 18:20:07 UTC XXX followers, XX engagements "Palatin Technologies: The Next Big Biotech Opportunity in Weight Loss 🚨 $PTNT $PTN According to the article Palatin Technologies currently trading on OTCQB may be a compelling turnaround story due to clinical successes across multiple billion-dollar markets. The article highlights Palatin's potential in the weight management industry where GLP-1 drugs like Ozempic and Wegovy face challenges with discontinuation due to side effects and weight regain. Palatin's Phase X obesity study showed that patients receiving bremelanotide alongside tirzepatide experienced more significant weight loss and"  [@TheCapitalJunky](/creator/x/TheCapitalJunky) on [X](/post/tweet/1947968669574746440) 2025-07-23 10:34:56 UTC XXX followers, XXX engagements "Dr. Reddy's Launches Sanofis Beyfortus in India: A Leap in Infant Healthcare 🚨 #DRREDDY $RDY According to the article Dr. Reddys Laboratories has launched Beyfortus (nirsevimab) in India a preventive treatment for Respiratory Syncytial Virus (RSV) in infants following an expanded partnership with Sanofi. The article highlights the underreported nature of RSV in India despite it causing a large amount of respiratory infections in infants. Experts claim almost every child contracts RSV by age two potentially leading to severe lung infections and hospitalizations. The launch of Beyfortus aligns"  [@TheCapitalJunky](/creator/x/TheCapitalJunky) on [X](/post/tweet/1945967986751197678) 2025-07-17 22:04:57 UTC XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@TheCapitalJunky
"Chevron Tesla and Oracle Lead Wave of Companies Leaving California by 2025 Over High Costs and Regulations"
@TheCapitalJunky on X 2025-07-28 18:20:07 UTC XXX followers, XX engagements
"Palatin Technologies: The Next Big Biotech Opportunity in Weight Loss 🚨 $PTNT $PTN According to the article Palatin Technologies currently trading on OTCQB may be a compelling turnaround story due to clinical successes across multiple billion-dollar markets. The article highlights Palatin's potential in the weight management industry where GLP-1 drugs like Ozempic and Wegovy face challenges with discontinuation due to side effects and weight regain. Palatin's Phase X obesity study showed that patients receiving bremelanotide alongside tirzepatide experienced more significant weight loss and" @TheCapitalJunky on X 2025-07-23 10:34:56 UTC XXX followers, XXX engagements
"Dr. Reddy's Launches Sanofis Beyfortus in India: A Leap in Infant Healthcare 🚨 #DRREDDY $RDY According to the article Dr. Reddys Laboratories has launched Beyfortus (nirsevimab) in India a preventive treatment for Respiratory Syncytial Virus (RSV) in infants following an expanded partnership with Sanofi. The article highlights the underreported nature of RSV in India despite it causing a large amount of respiratory infections in infants. Experts claim almost every child contracts RSV by age two potentially leading to severe lung infections and hospitalizations. The launch of Beyfortus aligns" @TheCapitalJunky on X 2025-07-17 22:04:57 UTC XXX followers, XXX engagements